SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ID Biomedical & Xillix Technologies
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: F. Jay Abella, III who wrote (11)2/18/1998 12:04:00 AM
From: Kaiser Soza  Read Replies (1) of 16
 
FJ, I think your call in December is working out with the shares up substantially since then. What do you make of the MRSA test? They figure they can get this thing into the market and achieve positive cash flow very quickly. These guys are elephant hunting in many markets which is great. I asked the company about the "scarce resources" especially before the recent small PP. In some respects I think they are so confident that they will soon hit another deal on CPT similar to the vaccine deal with Pasteur Merieux that they don't want to further dilute. I have owned the company since day one and sold about half the position I had and stuck with the rest. I agree with you on what seemed like a change of direction with the AIDS deal, but management has generally been quite good. Comments?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News